Atlas Trials

Michael Hoelscher

19 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Michael Hoelscher

RecordFirmDate
TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate (NCT06513286)Michael Hoelscher2025-06-12
Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral Treatment (NCT06267508)Michael Hoelscher2024-04-30
BTZ-043 Dose Evaluation in Combination and Selection (NCT05926466)Michael Hoelscher2023-09-21
PanACEA - STEP2C -01 (NCT05807399)Michael Hoelscher2023-04-14
SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia (NCT06435403)Michael Hoelscher2022-11-10
Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment (NCT04874948)Michael Hoelscher2021-10-08
PanACEA Sutezolid Dose-finding and Combination Evaluation (NCT03959566)Michael Hoelscher2021-05-06
BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA) (NCT04044001)Michael Hoelscher2019-11-15
Neonatal HIV Early Infant Diagnosis (EID) Versus Standard of Care EID- Long Term Impact on inFant hEalth (LIFE) (NCT04032522)Michael Hoelscher2019-10-23
Rapid and Accurate Diagnosis of Paediatric TB (RaPaed-AIDA-TB) (NCT03734172)Michael Hoelscher2019-01-21
A Single Ascending Dose Study of BTZ043 (NCT03590600)Michael Hoelscher2018-06-07
Identification of Broadly HIV-1 Neutralizing Antibodies (bNAb) in HIV-infected Patients in Mbeya, Tanzania. (NCT03334552)Michael Hoelscher2017-10-15

Track Michael Hoelscher automatically

Every clearance here is in the API, with alerts when new ones post.